Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC
Clinical trial NCT03970746 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03970746
- Sponsor
- PDC*line Pharma SAS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-10
- Primary completion
- 2024-07-18
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.